CI Investments Inc. lessened its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 11.3% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,648 shares of the biopharmaceutical company’s stock after selling 337 shares during the period. CI Investments Inc.’s holdings […]